Allogene Therapeutics ALLO
NASDAQ ALLO
$1.50 -0.04 (-2.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Allogene Therapeutics (ALLO) recorded Return on Capital Employed [ROCE] of -40.86% in Q2 2026, up 14.70 percentage points from -55.57% a year earlier and up 9.51 percentage points from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Allogene Therapeutics reported Return on Capital Employed [ROCE] of -46.54%, up 2.23 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -17.14 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -48.76% in FY2024 (-1.62 pp), -47.15% in FY2023 (-9.13 pp), -38.02% in FY2022 (-21.51 pp) and -16.51% in FY2021 (+12.89 pp).
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] since Q3 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in two of the last eight quarters, with an average year-over-year change of +0.28 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 14.70 percentage points in Q2 2026, against a drop of 25.60 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -50.37% (Q1 2026), -52.95% (Q4 2025) and -53.71% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Allogene Therapeutics 531.83 Mn 531.83 Mn - -40.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.86%
Mar 31, 2026 -50.37%
Dec 31, 2025 -52.95%
Sep 30, 2025 -53.71%
Jun 30, 2025 -55.57%
Mar 31, 2025 -53.96%
Dec 31, 2024 -51.22%
Sep 30, 2024 -50.87%
Jun 30, 2024 -49.89%
Mar 31, 2024 -51.08%
Dec 31, 2023 -51.13%
Sep 30, 2023 -48.04%
Jun 30, 2023 -50.71%
Mar 31, 2023 -48.81%
Dec 31, 2022 -41.72%
Sep 30, 2022 -27.07%
Jun 30, 2022 -25.21%
Mar 31, 2022 -23.22%
Dec 31, 2021 -17.72%
Sep 30, 2021 -23.94%
API Access

Allogene Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALLO&period=max&api_key=YOUR_API_KEY